Prenetics Global Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 13 Fair Values set on narratives written by author
US$17.85
10.03 (128.26%)
42.4% undervalued intrinsic discount
US$31.00
Fair Value
Price US$17.85
AnalystConsensusTarget US$31.00
Fair ValueUS$31.00
Share Pricen/a
PRE Community Narratives
AN
Fair Value
·Fair Value US$31 42.4% undervalued intrinsic discount
Bitcoin Treasury And Global Longevity Demand Will Drive Future Health Platform Expansion
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
Bitcoin Treasury And Global Longevity Demand Will Drive Future Health Platform Expansion
Catalysts About Prenetics Global Prenetics Global is a consumer health company focused on building IM8, a fast-scaling, science-backed health and longevity brand with a data-driven direct-to-consumer model. What are the underlying business or industry changes driving this perspective?Read more
AN

US$31
42.4% undervalued intrinsic discount
Fair Value
Profit Margin
34.21%
Future PE
3.29x
Price in 2028
US$38.34
Trending Discussion
Recently Updated Narratives
AN
Bitcoin Treasury And Global Longevity Demand Will Drive Future Health Platform Expansion
Fair Value: US$31 42.4% undervalued intrinsic discount
3 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Prenetics Global Limited Key Details
About PRE
- Founded
- 2014
- Employees
- 98
- CEO
- Website
View website
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.